Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 plus Nexavar in metastatic renal cell carcinoma
NCT00448149Phase 2Completed
- Sponsor
- Houston Methodist Research Institute
- Start
- Dec 2006
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in renal cell carcinoma (RCC), sponsored by Houston Methodist Research Institute. Started Dec 2006; status: completed.
02
Drugs
everolimus
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00448149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448149.